We invite you to visit and follow Patheon at: https://lnkd.in/dhTpAUb
关于我们
September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees.
Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon.
Visit our website at https://www.Patheon.com
- 网站
-
https://www.Patheon.com
Gallus BioPharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- St. Louis，MO
- 类型
- 私人持股
- 创立
- 2011
- 领域
- cGMP drug substance biomanufacturing、Mammalian Cell Culture、Process Development、Contract Development and Manufacturing、Single-Use and Stainless Steel Technologies、Clinical and Commercial Biomanufacturing和Aseptic Fill-Finish